Regeneron Co — Chief Scientific Officer Andrew J. Murphy Reports $12.9 Million Disposal of Common Shares
Regeneron Pharmaceuticals Co-Chief Scientific Officer Andrew J. Murphy sold 4,147 common shares on October 14, 2026. Murphy exercised non-qualified stock options for 17,000 common shares at $381.92 per share on October 13, 2026. He also disposed of 12,853 common shares at $754.58 per share on October 13. Following the